ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 160 filers reported holding ZIOPHARM ONCOLOGY INC in Q4 2020. The put-call ratio across all filers is 1.51 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $82 | -96.7% | 620 | -87.3% | 0.00% | – |
| Q2 2023 | $2,499 | -19.1% | 4,901 | 0.0% | 0.00% | – |
| Q1 2023 | $3,088 | -52.4% | 4,901 | -51.0% | 0.00% | -100.0% |
| Q4 2022 | $6,493 | -72.9% | 10,003 | -28.5% | 0.00% | 0.0% |
| Q3 2022 | $24,000 | +41.2% | 13,987 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $17,000 | +88.9% | 13,987 | -7.3% | 0.00% | – |
| Q1 2022 | $9,000 | -10.0% | 15,087 | +183.3% | 0.00% | -100.0% |
| Q3 2021 | $10,000 | -28.6% | 5,326 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $14,000 | -26.3% | 5,326 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $19,000 | 0.0% | 5,326 | -27.5% | 0.00% | 0.0% |
| Q3 2020 | $19,000 | +1800.0% | 7,348 | +1081.4% | 0.00% | – |
| Q4 2018 | $1,000 | -50.0% | 622 | +12.7% | 0.00% | – |
| Q3 2018 | $2,000 | -86.7% | 552 | -76.2% | 0.00% | -100.0% |
| Q1 2017 | $15,000 | -6.2% | 2,315 | -21.9% | 0.00% | -50.0% |
| Q4 2016 | $16,000 | – | 2,966 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 12,546,493 | $22,835,000 | 1.71% |
| MSD Partners, L.P. | 15,151,516 | $27,576,000 | 0.84% |
| MSD Partners, L.P. | 7,575,758 | $13,788,000 | 0.42% |
| CHIRON CAPITAL MANAGEMENT, LLC | 198,002 | $360,000 | 0.26% |
| Avidity Partners Management LP | 3,000,000 | $5,460,000 | 0.12% |
| Old West Investment Management, LLC | 211,513 | $384,000 | 0.10% |
| MAGNOLIA CAPITAL ADVISORS LLC | 103,239 | $188,000 | 0.07% |
| Virtus ETF Advisers LLC | 72,060 | $131,000 | 0.06% |
| ACT WEALTH MANAGEMENT, LLC | 34,454 | $91,000 | 0.06% |
| Allred Capital Management, LLC | 53,000 | $96,000 | 0.05% |